What is driving Plexus shares now Plexus (PLXS) has quietly outperformed the wider market over the past 3 months, with the stock up about 16% and roughly 9% over the past month, despite a slightly ...

Detailed price information for TTM Technologies (TTMI-Q) from The Globe and Mail including charting and trades.

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the electronic components & manufacturing industry, including Plexus (NASDAQ:PLXS) and its peers.

Plexus is in a buy zone after climbing above a 152.70 entry in a cup with handle. The proper buying range extends to 5% above the initial entry. Once a stock moves above that range, it's best to hold ...

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official hinted at a potential interest rate cut in December. John Williams, president of the Federal ...

Unlike almost everyone else, the banking sector escaped largely unscathed from the carnage of last week’s Budget.

Suburban shopping malls might be much better for dining these days, but not all are equal. We rank Brisbane’s largest from ...

Find out how to start and grow an in-person event business. You'll learn how to form strategic partnerships, find events that have your people, and the best way to sell your product. If you are ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

The global medical device contract manufacturing market is experiencing strong growth driven by rising demand for advanced, cost-efficient medical technologies and the increasing shift by OEMs toward ...